Effects of Zinc Sulfate Supplementation on Cell-Mediated Immune Response in Head and Neck Cancer Patients Treated with Radiation Therapy

REFERENCES

• Finn OJ: Immuno-oncology: Understanding the function and dysfunction of the immune system in cancer. Ann Oncol 23, viii6S–viii9S, 2012.
   Web of Science ®Google Scholar
• Reicher TE, Rabinowich H, Johnson JT, and Whiteside TL: Mechanisms responsible for signaling and functional defects. J Immunother 21, 295–306, 1998.
   PubMed Web of Science ®Google Scholar
• Corry J, Rischin D, Smith JG, D'Costa IA, Huges PG, et al.: Radiation with concurrent late chemotherapy intensification for locally advanced head and neck cancer. Radiother Oncol 54, 123–127, 2000.
   PubMed Web of Science ®Google Scholar
• Galdiero M, de Cinollaro I, Folgore A, Cappello M, Giobbe A, et al.: Effect of irradiation doses on alterations in cytokine release by monocytes and lymphocytes. J Med 25, 23–40, 1994.
   PubMedGoogle Scholar
• Belka C, Ottinger H, Kruzfelder E, Weinmann M, Lindemann M, et al.: Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol 50, 199–204, 1999.
   PubMed Web of Science ®Google Scholar
• Emma LV, Morales RB, Barrera-Franco JL, Poitevin AC, and Hadden J.: Long-term immune dysfunction after radiotherapy to the head and neck area. Int Immunopharm 3, 1093–1104, 2003.
   PubMed Web of Science ®Google Scholar
• Hu HM, Winter H, Urba WJ, and Fox BA: Divergent roles for CD4 T cells in the priming and effector/memory phases of adoptive immunotherapy. J Immunol 165, 4246–4253, 2000.
   PubMed Web of Science ®Google Scholar
• René EM, Ossendorp F, Offringa R, and Cornelis JMM: CD4 T cells and their role in antitumor immune responses. J Exp Med 189, 753–756, 1999.
   PubMed Web of Science ®Google Scholar
• Hung K, Hayashi R, Lafond WA, Lowenstein C, Paedoll D, et al.: The central role of CD4 T cells in the antitumor immune response. J Exp Med 188, 2357–2368, 1998.
   PubMed Web of Science ®Google Scholar
• Surman DR, Dudley ME, Overwijk WW, and Restifo NP: Cutting edge: CD4 T cell control of CD8 T cell reactivity to a model tumor antigen. J Immunol 164, 562–565, 2000.
   PubMed Web of Science ®Google Scholar
• Ossendorp F, Mengede E, Camps M, Filius R, and Melief CJ: Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J Exp Med 187, 693–702, 1998.
   PubMed Web of Science ®Google Scholar
• Hadden JW: The immunopharmacology of head and neck cancer: An update. Int J Immunopharmacol 19, 629–644, 1997.
   PubMed Web of Science ®Google Scholar
• Hilal EY, Wanebo HJ, Pinsky CM, Strong EM, and Oettgen HF: Immunologic evaluation and progress in patients with head and neck cancer. Am J Surg 134, 469–473, 1977.
   Web of Science ®Google Scholar
• Kay NE, Leong TL, and Bone N: Blood levels of immune cells predict survival in myeloma patients: Results of an Eastern Cooperative Oncology Group Phase 3 trial for newly diagnosed multiple myeloma patients. Blood 98, 23–28, 2001.
   PubMed Web of Science ®Google Scholar
• Murta EF, de Andrade JM, Falcao RP, and Bighetti S: Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumori 86, 403–407, 2000.
   PubMed Web of Science ®Google Scholar
• Hemberg M, Muhonen T, Turunen JP, Hahka-Kemppinen M, and Pyrohonen S: The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoinnumotherapy. J Clin Oncol 14, 1690–1696, 1996.
   PubMed Web of Science ®Google Scholar
• Kuss I, Hathaway B, Ferris RL, Gooding W, and Whiteside TL: Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the Head and Neck. Clin Cancer Res 10, 3755–3762, 2004.
   PubMed Web of Science ®Google Scholar
• Gray W, Chretien PB, Sutter CM, and Revie DR: Effects of radiotherapy on T lymphocyte subpopulation in patients with head and neck cancer. Otolaryngol Head Neck Surg 93, 650–660, 1985.
   PubMed Web of Science ®Google Scholar
• Mackall CL, Fleissher TA, Brown MR, and Andrich CC: Distinctions between CD8+ and CD4+ T cell regenerative pathways result in prolonged T cell imbalance after intensive chemotherapy. Blood 89, 3700–3707, 1997.
   PubMed Web of Science ®Google Scholar
• Chandra RK and McBean LD: Zinc and immunity. Nutrition 10, 79–80, 1994.
   PubMed Web of Science ®Google Scholar
• Hotz C and Brown KH: International Zinc Nutrition Consultative Group. Assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr Bull 25(Suppl.), 91–204, 2004.
   Google Scholar
• Shankar AH and Prasad AS: Zinc and immune function: The biological basis of altered resistance to infection. Am J Clin Nutr 68(Suppl), 447–463, 1998.
   PubMed Web of Science ®Google Scholar
• Walker FC and Black RE: Zinc and the risk for infectious disease. Annu Rev Nutr 24, 255–275, 2004.
   PubMed Web of Science ®Google Scholar
• Gray WC, Hasslinger BJ, Sutter CM, and Blanchards CL: Suppression of cellular immunity by head and neck irradiation. Arch Otolaryngol Suppression Head Neck Surg 112, 1185–1190, 1986.
   PubMed Web of Science ®Google Scholar
• Baqui AH, Black RE, Sak RB, Chowdhury HR, Yunus M, et al.: Malnutrition, cell-mediated immune deficiency, and diarrhea: A community based longitudinal study in rural Bangladeshi children. Am J Epidermiol 137, 355–365, 1993.
   PubMed Web of Science ®Google Scholar
• Black RE, Lanata CF, and Lazo F: Delayed cutaneous hypersensitivity: Epidemiologic factors affecting and usefulness in predicting diarrheal incidence in young Peruvian children. Pediatr Infect Dis J 8, 210–215, 1989.
   PubMed Web of Science ®Google Scholar
• Sazawal S, Black RE, Bhan MK, Jalla S, Sinha A, et al.: Zinc supplementation reduces the incidence of persistent diarrhea and dysentery among low socioeconomic children in India. J Nutr 126, 443–450, 1996.
   PubMed Web of Science ®Google Scholar
• Ripamonti C, Zecca E, and Brunelli C: A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 82, 1938–1945, 1998.
   PubMed Web of Science ®Google Scholar
• Ertekin MV, Koc M, Karslioglu I, and Sezen O: Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: A prospective, placebo-controlled, randomized study. Int J Radiat Oncol Biol 58, 167–174, 2004.
   PubMed Web of Science ®Google Scholar
• Ertekin MV, Koc M, Kaslioglu I, and Sezen O: The effects of oral zinc sulfate during radiotherapy on anti-oxidant enzyme activities in patients with head and neck cancer: A prospective, randomized, placebo-controlled study. Int J Clin Pract 58, 662–668, 2004.
   PubMed Web of Science ®Google Scholar
• Lin LC, Que J, Lin LK, and Lin FC: Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head and neck cancers: A double blind, randomized study. Int J Radiat Oncol Biol Phys 65, 745–750, 2006.
   PubMed Web of Science ®Google Scholar
• Hadden JW: Thymic endocrinology. Int J Immunopharmacol 14, 345–352, 1992.
   PubMed Web of Science ®Google Scholar
• Sundermann FW: The influence of zinc on apoptosis. Ann Clin Lab Sci 25, 134–142, 1995.
   PubMed Web of Science ®Google Scholar
• Prasad AS, Meftah S, Abdallah J, Kaplan J, Brewer GJ, et al.: Serum thymulin in human zinc deficiency. J Clin Invest 82, 1202–1210, 1988.
   PubMed Web of Science ®Google Scholar
• Zorbas YG, Kakuris KK, Neofitov IA, and Afoninos NI: Zinc utilization in zinc-supplemented and-unsupplemented healthy subjects during and after prolonged hypokinesis. Tr Elem Electro 25, 60–68, 2008.
   Web of Science ®Google Scholar
• Lin LC, Que J, Lin LK, Lin FC, Leung HWC, et al.: Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: A double blind, randomized study. Int J Radiat Oncol Biol Phys 70, 368–373, 2008.
   PubMed Web of Science ®Google Scholar
• Lin YS, Lin LC, and Lin SW: Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: Follow-up of a double-blind randomized study with subgroup analysis. Laryngoscope 119, 1348–1352, 2009.
   PubMed Web of Science ®Google Scholar
• Percival SS: Neutropenia caused by copper deficiency: Possible mechanisms of action. Nutr Rev 53, 59–66, 1995.
   PubMed Web of Science ®Google Scholar
• Kelly EJ, Quaife CJ, Froelick GJ, and Palmiter RD: Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J Nutr 126, 1782–1790, 1996.
   PubMed Web of Science ®Google Scholar
• National Research Council: Recommended Dietary Allowances, 10th ed. Washington, DC: National Academy Press, 1989.
   Google Scholar
• Hiroyuki Y: Zinc Deficiency and Clinical Practice. The Journal of the Japan Medical Association 129, 613–616, 2003.
   Google Scholar
• King JC: Assessment of zinc status. J Nutr 120, 1474–1479, 1990.
   PubMed Web of Science ®Google Scholar
• Prasad AS, Kaplan J, and Beck EW: Trace elements in head and neck cancer patients: Zinc status and immunologic functions. Otolaryngol Head Neck Surg 116, 624–629, 1997.
   PubMed Web of Science ®Google Scholar
• Prasad AS, Beck FW, and Doerr TD: Nutritional and zinc status of head and neck cancer patients: An interpretive review. J Am Coll Nutr 17, 409–418, 1998.
   PubMed Web of Science ®Google Scholar